Herbalife price target raised to $13 from $9.50 at DA Davidson

DA Davidson raised the firm’s price target on Herbalife to $13 from $9.50 and keeps a Neutral rating on the shares. The company reported a Q2 revenue miss due to shortfalls in Asia, though its EBITDA beat consensus by $31M, the analyst tells investors in a research note. Herbalife new distributor growth was also positive for the first time in 12 quarters, which should be followed by stronger constant-currency sales growth at some point in the future, the firm added.